CYP

1.82%

27.0¢ cynata therapeutics limited

Ann: CYP Presents at Major International Cell Therapy Conference, page-21

First 21 Last

Share
Profile

Follow
Blinger

216 Posts.

35

03/06/24

21:12

Post #: 74145429
Share

Originally posted by bedger: ↑

Come on dude. This is not buying a used car.

(Caveat for all others - we are not talking an actual implied takeover here, just the subject around Sumitomo if they were return)

You know how long this stuff takes. They'd have to go through all the due dilligence again, get auditors involved, etc. They can't time all that on the low - we can't even with small liquid purchases, let alone them with the inertia of a full blown takeover. They can start buying on market in small amounts when under $20 million mkt cap (and indeed might of), but even they even bought $1 million stock back then, they'd tip the market with the 5% voting power/ownership disclosure rules on the ASX.

https://www.biospace.com/article/biospace-mergers-and-acquisitions-tracker/

Pick a few recent biotech takeovers. They've mostly been many months, even years in the making. But they are dfeinitely picking up:

https://www.bloomberg.com/news/articles/2024-03-14/biotech-rally-gets-100-billion-m-a-lift-with-more-deals-to-come?embedded-checkout=true

And no wonder. Bargains in the bio-tech space with big Pharma sat on over $1 trillion in cash and easy pickings like Cynata abound:

"Pharmaceutical companies have taken advantage of favorable valuations in the biotech sector to pursue opportunistic purchases. And they have the resources at hand, drawing on deep cash reserves amassed during COVID-19, estimated at US$1.4 trillion as of December 2023."

https://mergers.whitecase.com/highlights/oncology-dealmaking-fuels-biotech-ma

Expand

I answered your first question clearly, NO.

"Isn't that reverse logic. You are saying Sumitomo wouldn't buy CYP because its so low?"

NO.
ok dude

Last edited by Blinger: 03/06/24

CYP Price at posting: 32.0¢ Sentiment: Buy Disclosure: Held
3 Upvote

0 Great analysis

Reply

Top Stories

WCN

White Cliff jumps 24% on 'bonanza grade' copper rock chips at Rae project, Canada

ACW

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

Week 40 Wrap: China's nonsensical stimmy hype wanes (shocking!); HotCopper's picks; oil & inflation

BUX

Buxton projects new graphite province discovery at WA Narryer play

RCE

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

SLS

Solstice Minerals to ramp up drilling campaign at Yarri Gold Project

BCI

BCI reaches close of funding facility for salt-first part of Mardie project

NTI

Neurotech knocked back by FDA as agency declares target condition not rare enough for special status

CKA

Cokal upgrades infrastructure for BBM ramp-up in Indonesia

COD

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

First 21 Last

Add CYP (ASX) to my watchlist

(20min delay)
Last 27.0¢		Change -0.005(1.82%)		Mkt cap ! $48.78M

Open	High	Low	Value	Volume
27.5¢	28.5¢	26.5¢	$71.17K	257.3K

Buyers (Bids)

No.	Vol.	Price($)
4	145786	27.0¢

Sellers (Offers)

Price($)	Vol.	No.
28.0¢	15000	1

View Market Depth

No.	Vol.	Price($)
4	145786	0.270
3	12000	0.265
2	105000	0.260
3	14799	0.250
1	10000	0.245

Price($)	Vol.	No.
0.280	15000	1
0.290	36000	1
0.295	25028	2
0.300	72500	2
0.305	29140	1

Last trade - 16.10pm 04/10/2024 (20 minute delay)

CYP (ASX) Chart

Ann: CYP Presents at Major International Cell Therapy Conference, page-21

White Cliff jumps 24% on 'bonanza grade' copper rock chips at Rae project, Canada

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

Week 40 Wrap: China's nonsensical stimmy hype wanes (shocking!); HotCopper's picks; oil & inflation

Buxton projects new graphite province discovery at WA Narryer play

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

Solstice Minerals to ramp up drilling campaign at Yarri Gold Project

BCI reaches close of funding facility for salt-first part of Mardie project

Neurotech knocked back by FDA as agency declares target condition not rare enough for special status

Cokal upgrades infrastructure for BBM ramp-up in Indonesia

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

Ann: CYP Presents at Major International Cell Therapy Conference, page-21

Top Stories

White Cliff jumps 24% on 'bonanza grade' copper rock chips at Rae project, Canada

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

Week 40 Wrap: China's nonsensical stimmy hype wanes (shocking!); HotCopper's picks; oil & inflation

Buxton projects new graphite province discovery at WA Narryer play

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

Solstice Minerals to ramp up drilling campaign at Yarri Gold Project

BCI reaches close of funding facility for salt-first part of Mardie project

Neurotech knocked back by FDA as agency declares target condition not rare enough for special status

Cokal upgrades infrastructure for BBM ramp-up in Indonesia

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News